Mon08032020

Robins Global News & Noticias



COVID-19 Map Tracker | COVID-19 News Features


  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI)


LOS ANGELES, July 31, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 17, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Chembio Diagnostics, Inc. ("Chembio" or the "Company") (NASDAQ: CEMI) common stock between March 12, 2020 and June 16, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Chembio investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/chembio-diagnostics-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at This email address is being protected from spambots. You need JavaScript enabled to view it. to learn more about your rights.

In April 2020, the Company’s COVID-19 antibody test was one of the first to be granted Emergency Use Authorization (“EUA”) by the U.S. Food and Drug Administration (“FDA”).

Then, on June 17, 2020, before the market opened, the FDA revoked the EUA for Chembio’s Dual Path Platform COVID-19 serology test due to concerns regarding the test’s accuracy. Specifically, the FDA found that the “benefits no longer outweigh its risks” and that “it is not reasonable to believe that the test may be effective” because  it “generates a higher than expected rate of false results and higher than that reflected in the authorized labeling for the device.”

On this news, the Company’s share price fell $6.04, or nearly 60%, to close at $3.89 per share on June 17, 2020.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Chembio common stock during the Class Period, you may move the Court no later than August 17, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to This email address is being protected from spambots. You need JavaScript enabled to view it., or visit our website at www.glancylaw.com.  If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.glancylaw.com



Posted: 2020-07-31 16:00:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.





Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI) | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI)

Fri, 31 Jul 2020 09:24:00 GMT

2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Chembio Diagnostics, Inc. ("Chembio" or the "Company") (NASDAQ: CEMI) common stock between March 12 ...

Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Chembio Diagnostics, Inc. Investors

Tue, 28 Jul 2020 15:17:00 GMT

The law firm of Kessler Topaz Meltzer & Check, LLP reminds Chembio Diagnostics, Inc. (NASDAQ:CEMI) ("Chembio") investors ...

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Chembio Diagnostics, Inc. IMPORTANT UPCOMING DEADLINE CEMI

Mon, 27 Jul 2020 16:37:00 GMT

The lawsuit seeks to recover damages for Chembio Diagnostics, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 ...

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Chembio Diagnostics, Inc. -IMPORTANT UPCOMING DEADLINE- CEMI

Mon, 27 Jul 2020 07:42:00 GMT

NEW YORK, July 27, Jul 27, 2020 (GLOBE NEWSWIRE via COMTEX) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Chembio ...

ROSEN, A TOP RANKED LAW FIRM, Reminds Chembio Diagnostics, Inc. Investors of Important Deadline in Securities Class Action – CEMI

Sun, 26 Jul 2020 19:38:00 GMT

2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Chembio investors under the federal securities laws. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION.

Related News Story Videos From Youtube






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.